Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
J Inherit Metab Dis ; 27(2): 115-25, 2004.
Artículo en Inglés | MEDLINE | ID: mdl-15159642

RESUMEN

Executive functions were studied in 14 early and continuously treated PKU subjects (age 10.8 years, range 8-13) in comparison with controls matched for IQ, sex, age and socioeconomic status. Brain MRI examination was normal in all PKU patients. Neuropsychological evaluation included Wisconsin Card Sorting Test, Rey-Osterreith Complex Figure Test, Elithorn's Perceptual Maze Test, Weigl's Sorting Test, Tower of London, Visual Search and Motor Motor Learning Test. Whatever the IQ, PKU subjects performed worse than controls in tests exploring executive functions. Subgrouping the PKU subjects according to the quality of dietary control for the entire follow-up period (using 400 micromol/L as cut-off value for blood phenylalanine (Phe) concentration) showed that patients with worse dietary control performed more poorly than both the PKU group with the best dietary control and the control group. However, a mild impairment of executive functions was still found in PKU patients with a good dietary control (Phe <400 micromol/L) compared to controls. Concerning the PKU group as a whole, no linear correlation was found between neuropsychological performance and historical and concurrent biochemical parameters. We conclude that (a) PKU patients, even when treated early, rigorously and continuously, show an impairment of frontal lobe functions; (b) a protracted exposure to moderately high levels of Phe can affect frontal lobe functions independently of the possible effect of the same exposure on IQ; (c) in order to reduce the risk of frontal lobe dysfunction, the target of dietary therapy should be to maintain blood Phe concentration below 400 micromol/L.


Asunto(s)
Trastornos del Conocimiento/etiología , Trastornos del Conocimiento/fisiopatología , Lóbulo Frontal/fisiopatología , Fenilcetonurias/complicaciones , Fenilcetonurias/fisiopatología , Adolescente , Niño , Trastornos del Conocimiento/diagnóstico , Femenino , Lóbulo Frontal/crecimiento & desarrollo , Humanos , Inteligencia , Masculino , Pruebas Neuropsicológicas , Fenilcetonurias/dietoterapia , Pronóstico , Clase Social
2.
Neurology ; 59(8): 1241-3, 2002 Oct 22.
Artículo en Inglés | MEDLINE | ID: mdl-12391354

RESUMEN

The authors report a kindred in which GTP-CH deficiency resulted in a myoclonus-dystonia syndrome. The proband, a 17-year-old boy, presented with early-onset myoclonus and later, dystonia and bradykinesia. Blood prolactin was increased and CSF homovanillic acid, 5-hydroxyindoleacetic acid, and biopterin were all reduced. L-Dopa/carbidopa administration resulted in clinical improvement. In the paternal branch, the grandfather and three relatives had myoclonus-dystonia and resting or postural tremor of limbs. The authors found a missense mutation in the exon 6 of GCH-1 gene (K224R).


Asunto(s)
Distonía/genética , GTP Ciclohidrolasa/deficiencia , GTP Ciclohidrolasa/genética , Levodopa/uso terapéutico , Mioclonía/genética , Adolescente , Adulto , Diagnóstico Diferencial , Distonía/diagnóstico , Distonía/tratamiento farmacológico , Distonía/enzimología , Femenino , Genes Dominantes/genética , Tamización de Portadores Genéticos , Humanos , Masculino , Persona de Mediana Edad , Mutación Missense/genética , Mioclonía/diagnóstico , Mioclonía/tratamiento farmacológico , Mioclonía/enzimología , Linaje , Síndrome
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...